Live from ClinicalTrials.gov + Open Targets, fetched 2026-11-12 02:07 UTC. Every row links to its source record.
Postmortem · what the sponsor and named sources said, kept apart from what merely happened at the same time
Is There an Interest in Repeating the Vaginal Administration of Dinoprostone (Propess®), to Promote Induction of Labor of Pregnant Women at Term?
NCT02888041 · University Hospital, Limoges · PHASE3 · terminated · last registry update 2024-08-28 · Decision brief
No research has been run for this trial yet, so only the registry's own reason and the timeline are shown.
What was said, and by whom
Stated is the sponsor's own words; Reported is a named third party. The category is our label from a fixed list; the quote is the evidence.
| Kind | Quote | Our category | Source |
|---|---|---|---|
| Stated | “Not enough patients” | – | Registry record, University Hospital, Limoges |
Also happening at the time. Not shown to be a cause.
Registry events on other trials of drugs against PTGER1 within 12 months either side of this trial's last update, live from ClinicalTrials.gov. Nothing here was stated as a reason.
- 2025-04-09Results posted on the registry: Mayo Clinic, a drug against PTGER1 (NCT05199233)
- 2025-01-17Also stopped (terminated): Hospital Kemaman, Intravaginal prostaglandin E2 (NCT05622968)
- 2024-12-27Results posted on the registry: Mayo Clinic, a drug against PTGER1 (NCT04743973)
- 2024-11-21Also stopped (terminated): CSPC ZhongQi Pharmaceutical Technology Co., Ltd., Alprostadil liposome injection (NCT05475717)
- 2024-09-03Results posted on the registry: Mayo Clinic, a drug against PTGER1 (NCT04720053)
- 2024-08-15Results posted on the registry: Centre Hospitalier Departemental Vendee, Dinoprostone (NCT02649920)
- 2024-08-15Also stopped (terminated): Centre Hospitalier Departemental Vendee, Dinoprostone (NCT02649920)
- 2024-07-31Phase 3 first posted: National University Hospital, Singapore, Menopausal hormone therapy + Menopausal hormone therapy + exercise training (NCT06530459)
- 2024-07-19Results posted on the registry: Columbia University, Misoprostol (NCT03670836)
- 2023-09-15Also stopped (withdrawn): Alonso Vera Torres, Analogs, Prostaglandin E1 + Standard therapeutic protocol (NCT04536363)
- 2023-09-15Also stopped (suspended): Guangzhou Women and Children's Medical Center, Induction of labor with PGE2 (NCT04780269)
- 2023-08-30Results posted on the registry: Ruth M. Rothstein CORE Center, Lubiprostone (NCT01839734)
What is not public
- Internal portfolio and board discussions
- Unpublished trial data and interim analyses
- Terms of any partner or licence decision